Alere announced the launch of its Alere iCup Rx Drug Screen, a test designed to detect five of the most commonly misused and abused drugs—benzodiazepines, buprenorphine, methadone, opiates, and oxycodone—in urine.
Alere iCup Rx is a lateral flow chromatographic immunoassay that allows addiction specialists and physicians to screen for abuse and help improve patient compliance. The iCup Rx is the first rapid urine test to validate five of the most relevant prescription drugs at once.
“An easy-to-use test that provides actionable results during a patient visit is a valuable first-line tool to detect potential opioid abuse and, when it occurs, to get these patients the specific addiction treatment they need,” said Robert L. DuPont, MD, Clinical Professor of Psychiatry at the Georgetown University School of Medicine and Director of the National Institute on Drug Abuse (NIDA).
View full article source: http://www.empr.com/news/urine-test-benzodiazepines-buprenorphine-opiates-oxycodone-methadone/article/676152/